New constrained hip liner shows promising mid-term results in complex revision surgery

Surgeons wrestling with one of the most stubborn complications in hip replacement surgery—recurrent dislocation—may have gained a valuable new tool, according to a retrospective study published in Archives of Orthopaedic and Trauma Surgery. Researchers at a single urban academic center followed 32 patients who underwent 37 complex revision total hip arthroplasties using a next-generation constrained acetabular liner, and they report that none of the revised implants showed wear, breakage, aseptic loosening of the acetabular cup, or periprosthetic fracture over an average follow-up of 4.7 years. The findings, while drawn from a small and highly selected cohort, offer a mid-term look at a device designed to address the historic failure modes of older constrained liner designs.

Dislocation remains one of the most common and challenging complications after total hip arthroplasty. Reported rates vary widely across registries and large series, ranging from 0.2 to 0.7 percent of primary procedures in some registries, between 1.9 and 10 percent in other large series, and up to 9.0 percent in revision surgeries.

Constrained acetabular liners were developed precisely for these high-risk situations. Unlike standard liners, they capture the femoral head within a polyethylene shell that extends beyond the head’s equator, mechanically preventing the head from slipping out of the socket. This makes them a common salvage option for patients with severe instability or compromised soft-tissue support, such as those with abductor muscle deficiency. But first-generation designs introduced their own problems: the very constraint that prevents dislocation also concentrates stress at the bone-implant interface, contributing to aseptic loosening, liner failure, and locking-mechanism breakdown. Repetitive impingement within a reduced arc of motion can generate polyethylene fatigue fractures and locking failures, and prior studies have reported aseptic loosening incidences between 2 and 7 percent, with implant wear, breakage, and periprosthetic fracture cumulatively occurring in an additional 2 to 3 percent of patients.

The device examined in the new study, the G7 Freedom Constrained Liner, was designed to mitigate these shortcomings. It features a highly cross-linked polyethylene liner with a modular 32-mm or 36-mm cobalt-chromium femoral head that has a flat equatorial section angled at 15 degrees to the vertical axis. According to the researchers, this geometry increases the force required to produce a femoral head dislocation while providing a greater range of motion before impingement. The liner also incorporates cut-outs with focal areas of constraint, allowing surgeons to tailor the safe zone to an individual patient’s spinopelvic kinematics—a design philosophy the authors describe as patient-specific rather than universally restrictive.

The study team, led by Farouk Khury and colleagues including senior author Vinay K. Aggarwal, retrospectively reviewed patients who underwent revision total hip arthroplasty with the next-generation liner between March 2017 and October 2023 at a single, urban, high-volume academic hospital. Of 48 patients initially identified, 16 were excluded because of missing follow-up data, leaving 32 patients and 37 procedures. The mean age at surgery was 71.8 years, the mean body mass index was 27.2 kg/m², and the majority of patients were female (71.9 percent) and White (81.3 percent). The mean follow-up duration was 4.7 years, with a range extending from 0.3 to 9.7 years.

The cohort reflected the complexity of the cases involved. The most common indication for revision was instability, accounting for 70.3 percent of procedures, followed by infection at 16.2 percent, aseptic loosening at 10.8 percent, and polyethylene wear at 2.7 percent. Twelve patients—37.5 percent of the cohort—had undergone a total of 24 prior revisions before receiving the constrained liner, including seventeen revisions for infection, five for instability, and two for aseptic loosening. The preoperative constructs varied widely: fourteen procedures involved an existing standard fixed-bearing construct, twelve a dual-mobility construct, five an existing next-generation constrained liner, four a constrained liner from a different manufacturer, one a static spacer, and one a hemiarthroplasty. In most cases—70.3 percent—the new liner was implanted into a pre-existing acetabular cup, while 29.7 percent of procedures involved revision of both the cup and the liner.

The key outcomes were encouraging. No cases of implant wear, breakage, acetabular cup aseptic loosening, or periprosthetic fracture were observed following the revision procedures. Radiographic evaluation was feasible for 35 of the 37 procedures, and at latest follow-up, radiolucent lines were observed in only one case, with no instances of implant migration or eccentric seating. The mean acetabular inclination was 44.3 degrees with a mean anteversion of 15.9 degrees, and the researchers reported that component orientation was well preserved over time. However, the device was not without failures: six patients, or 18.8 percent of the cohort, underwent a total of sixteen subsequent reoperations after the constrained liner was implanted—ten for instability and six for infection. Among the instability-related reoperations, four involved revision to a new next-generation constrained liner, two were open reductions, one was revised to a dual-mobility construct, one to an elevated liner, one to a dual-mobility articulation in a revised cup, and one was a resection arthroplasty performed for severe soft-tissue deficiency. Survivorship free from all-cause reoperation was 83.8 percent at one year and 72.6 percent at latest follow-up, with no statistically significant difference between aseptic and septic indication groups.

The authors place their one-year survivorship figure in context by comparing it with other contemporary constrained liners. In a recent systematic review cited in the study, an overall reoperation-free survivorship of 79.9 percent at latest follow-up was reported for patients treated with constrained liners. The researchers acknowledge that the 72.6 percent survivorship at latest follow-up is lower than standard revision benchmarks, but they argue it must be understood within the context of this highly complex revision cohort, in which many patients had already failed multiple prior constructs, including dual-mobility implants and other constrained liners. They also note that modern dual-mobility constructs, a common alternative in high-risk instability cases, carry their own complication risks, such as intraprosthetic dissociation and liner malseating, which is part of why constrained liners remain in the surgical armamentarium.

The study has important limitations that the authors themselves detail. The sample size is inherently limited by the selective use of constrained liners in only the most complex hip replacements, limiting generalizability. Even at a center where revision procedures account for approximately 2 percent of the total joint arthroplasty caseload, this cohort of 32 patients represents a highly select subset of the most complex cases. The comparative survivorship analysis between septic and aseptic groups included only six septic cases and is underpowered. As a retrospective study at a single high-volume academic center, the work is subject to selection bias, compounded by the exclusion of 16 patients without follow-up. Variations in surgical technique and postoperative management likely existed among the multiple fellowship-trained surgeons involved, and retrospective data collection limited the ability to capture granular, patient-specific variables such as baseline spinopelvic mobility. Strict radiographic measurements could be performed on only 35 of the 37 procedures due to inadequate imaging. Notably, the study did not include patient-reported outcome measures—a major limitation, the authors concede, given that recurrent instability severely impacts function and quality of life.

Despite these constraints, the researchers conclude that the next-generation constrained acetabular liner provides favorable mid-term clinical outcomes and reoperation-free survivorship in complex revision total hip arthroplasty, and that its focal constraint design—adapting to individualized soft-tissue and bony deficiencies—represents a meaningful step toward tailored arthroplasty. They call for ongoing follow-up and larger multicenter studies with standardized patient-reported outcome measures and longer follow-up to determine whether these encouraging mid-term results translate into long-term durability and sustained patient-specific success.

Subject of Research: Mid-term outcomes of a next-generation constrained acetabular liner in high-risk revision total hip arthroplasty

Article Title: Patient-specific management in high-risk revision total hip arthroplasty: mid-term outcomes of a next-generation constrained acetabular liner

Article References: Khury, F., Luebbering, B., Ruff, G., Bahlouli, L., Sarfraz, A., Schwarzkopf, R., & Aggarwal, V. K. (2026). Patient-specific management in high-risk revision total hip arthroplasty: mid-term outcomes of a next-generation constrained acetabular liner. Archives of Orthopaedic and Trauma Surgery, 146(1), Article 375. https://doi.org/10.1007/s00402-026-06527-6

Image Credits: AI Generated

DOI: 10.1007/s00402-026-06527-6

Keywords: total hip arthroplasty, revision surgery, constrained acetabular liner, recurrent dislocation, implant survivorship, aseptic loosening, dual-mobility constructs, periprosthetic fracture, abductor deficiency, orthopaedic surgery, reoperation, hip instability